Skip to main content

Understanding and targeting the functional consequences of aneuploidy in cancer

Project description

Targeting the Achilles heel of cancer

Cancer cells often present with an imbalanced number of chromosomes or chromosomal translocations. Despite extensive research into the origin of aneuploidy, its underlying mechanisms have not been fully elucidated. The EU-funded CancerAneuploidy project aims to study the cellular consequences of aneuploidy. To achieve this, scientists will use state-of-the-art genomic approaches and chemical perturbation and investigate the evolution of aneuploidy in tumours. The discovery of the vulnerabilities caused by aneuploidy has the potential to be exploited for killing cancer cells. Collectively, the project's results will shed light on the biological enigma of aneuploidy and offer new opportunities for cancer therapy.

Call for proposal

ERC-2020-STG
See other projects for this call

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Host institution

TEL AVIV UNIVERSITY
Address
Ramat Aviv
69978 Tel Aviv
Israel
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 612 500

Beneficiaries (1)

TEL AVIV UNIVERSITY
Israel
EU contribution
€ 1 612 500
Address
Ramat Aviv
69978 Tel Aviv
Activity type
Higher or Secondary Education Establishments